Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Transplant Proc ; 51(2): 429-432, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30879558

RESUMEN

BACKGROUND: Familial amyloidosis polyneuropathy (FAP) is a rare, progressive, and life-threatening disease inherited in the autosomal dominant pattern. Liver transplantation is the only proven disease-modifying treatment to date. AIM: To study the long-term outcomes of patients transplanted for FAP under a multidisciplinary team care. METHODS: We included adult patients who were transplanted for FAP indication and were followed up in a relevant clinic or admitted in our department. RESULTS: Twelve patients (6 male) with a mean age of 43 years and mean follow-up post-transplant of 100 months were included. Three patients died in this period, 1 due to a disease-related cause. All patients had peripheral neuropathy (25% severe). Eighty-three percent had autonomic nervous system dysfunction; all men, except one, erectile dysfunction; and half of the patients several genitourinary manifestations. Gastrointestinal involvement was present in 75% of the patients. The severity of several complications related to FAP was found to be associated with waiting on the transplant list for more than 12 months. CONCLUSIONS: Patients transplanted for FAP have a long survival. Prolonged stay on the transplant waiting list is associated with frequency and severity of disease complications. These patients are best managed in the context of multidisciplinary team care.


Asunto(s)
Neuropatías Amiloides Familiares/cirugía , Trasplante de Hígado/métodos , Adulto , Anciano , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Resultado del Tratamiento
2.
Acta Anaesthesiol Scand ; 57(1): 126-32, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23078544

RESUMEN

BACKGROUND: Predictors of laterality of motor block during epidural analgesia are currently unknown, as studies so far have yielded conflicting results. We aimed to evaluate predictors of post-operative asymmetric lower extremity motor blockade in a mixed surgical population. METHODS: This is a retrospective analysis of 578 consecutive patients with post-operative epidural analgesia for a variety of surgical procedures. A priori determined potential predictors of unilateral motor block were age, gender, body mass index, type of surgical procedure, vertebral level of puncture, catheter insertion depth into the epidural space and concentration of local anaesthetic. Logistic regression analysis was employed for evaluating predictors of laterality. RESULTS: Unilateral motor block occurred in 29.2% of the patients. Univariate logistic regression analysis showed that young age, female gender, gynaecologic procedures, a low puncture level, an increased depth of catheter insertion and a high ropivacaine concentration (2 mg/ml vs. less than 2 mg/ml) were significantly associated with increased incidence of laterality. Multivariate analysis revealed that age (OR = 0.73 per decade increase, P = 0.00001), the vertebral level of epidural puncture (OR = 1.37 per lowering vertebral level, P < 0.000001) and the depth of catheter insertion (OR = 1.46 per centimetre deeper, P = 0.001) were independent predictors of unilateral motor block. CONCLUSION: These results suggest that young patients with lumbar epidural analgesia or deep catheter insertion should be frequently monitored for the occurrence of laterality of motor block. Also, these results provide support for a prospective study to determine the optimal catheter insertion depth to decrease the risk of unilateral motor block.


Asunto(s)
Analgesia Epidural/efectos adversos , Bloqueo Neuromuscular/efectos adversos , Adolescente , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Analgesia Epidural/estadística & datos numéricos , Anestésicos Locales/administración & dosificación , Índice de Masa Corporal , Cateterismo , Relación Dosis-Respuesta a Droga , Femenino , Lateralidad Funcional/fisiología , Humanos , Modelos Logísticos , Extremidad Inferior , Masculino , Persona de Mediana Edad , Análisis Multivariante , Bloqueo Neuromuscular/estadística & datos numéricos , Dolor Postoperatorio/tratamiento farmacológico , Valor Predictivo de las Pruebas , Punciones , Estudios Retrospectivos , Factores Sexuales , Procedimientos Quirúrgicos Operativos , Adulto Joven
5.
J Neurosci Res ; 66(5): 899-908, 2001 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-11746417

RESUMEN

Glutamate dehydrogenase (GDH) catalyzes the oxidative deamination of glutamate to alpha-ketoglutarate using NAD or NADP as cofactors. In mammalian brain, GDH is located predominantly in astrocytes, where it is probably involved in the metabolism of transmitter glutamate. The exact mechanisms that regulate glutamate fluxes through this pathway, however, have not been fully understood. In the human, GDH exists in heat-resistant and heat-labile isoforms, encoded by the GLUD1 (housekeeping) and GLUD2 (nerve tissue-specific) genes, respectively. These forms differ in their catalytic and allosteric properties. Kinetic studies showed that the K(m) value for glutamate for the nerve tissue GDH is within the range of glutamate levels in astrocytes (2.43 mM), whereas for the housekeeping enzyme, this value is significantly higher (7.64 mM; P < 0.01). The allosteric activators ADP (0.1-1.0 mM) and L-leucine (1.0-10.0 mM) induce a concentration-dependent enzyme stimulation that is proportionally greater for the nerve tissue-specific GDH (up to 1,600%) than for the housekeeping enzyme (up to 150%). When used together at lower concentrations, ADP (10-50 mM) and L-leucine (75-200 microM) act synergistically in stimulating GDH activity. GTP exerts a powerful inhibitory effect (IC(50) = 0.20 mM) on the housekeeping GDH; in contrast, the nerve tissue isoenzyme is resistant to GTP inhibition. Thus, although the housekeeping GDH is regulated primarily by GTP, the nerve tissue GDH activity depends largely on available ADP or L-leucine levels. Conditions associated with enhanced hydrolysis of ATP to ADP (e.g., intense glutamatergic transmission) are likely to activate nerve tissue-specific GDH leading to an increased glutamate flux through this pathway.


Asunto(s)
Amoníaco/metabolismo , Encéfalo/enzimología , Metabolismo Energético/fisiología , Glutamato Deshidrogenasa/metabolismo , Ácido Glutámico/metabolismo , Adenosina Difosfato/metabolismo , Animales , Encéfalo/efectos de los fármacos , Glutamato Deshidrogenasa/genética , Humanos , Leucina/metabolismo , Isoformas de Proteínas/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo
6.
J Neurosci Res ; 66(5): 909-13, 2001 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-11746418

RESUMEN

Glutamate dehydrogenase (GDH) specific activities, kinetic properties and allosteric regulation were studied in extracts from cultured neurons and astrocytes prepared from mouse cerebral cortex and cerebellum. Considerable differences were observed in the specific activity of the enzyme among the different cell types with astrocytes expressing the highest GDH activity. This may reflect the functional importance of these cells in glutamate uptake and metabolism. Among the neurons, the glutamatergic cerebellar granule cells showed a GDH specific activity that was 60% higher (P < 0.01) than that of the GABAergic cerebral cortical neurons. Also, the K(m) for ammonia was 1.7-fold higher in the cortical neurons than in the other cell types. These findings may reflect a particular need for the glutamatergic granule cells to synthesize glutamate via the GDH pathway. No differences were observed among the different cell types with regard to the allosteric properties of GDH expressed by these cells.


Asunto(s)
Astrocitos/enzimología , Cerebelo/enzimología , Corteza Cerebral/enzimología , Glutamato Deshidrogenasa/metabolismo , Ácido Glutámico/metabolismo , Neuronas/enzimología , Adenosina Difosfato/metabolismo , Adenosina Difosfato/farmacología , Animales , Animales Recién Nacidos , Astrocitos/citología , Células Cultivadas , Cerebelo/citología , Corteza Cerebral/citología , Glutamato Deshidrogenasa/antagonistas & inhibidores , Guanosina Trifosfato/metabolismo , Guanosina Trifosfato/farmacología , Cinética , Ratones , Neuronas/citología
7.
Ann Neurol ; 50(2): 227-33, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11506406

RESUMEN

Since the spring of 1997, when the Neurology Department of the University Hospital of Crete admitted its first patient, nine cases (eight neuropathologically confirmed and one probable) of sporadic Creutzfeldt-Jakob disease (sCJD) have been recorded. This represents an annual incidence five-fold higher than expected based on the island's population (0.54 million). Molecular analysis of the prion-protein gene (PRNP) showed no mutations in any of the seven CJD cases studied. Five patients (ages 64-88 years) were homozygous for methionine-129 of PRNP and showed the classic sCJD triad (subacute dementia, myoclonus, periodic electroencephalogram). Brains contained type 1 (unglycosylated 21.5 kDa band) protease-resistant prion protein (PrPres). Two patients (ages 56 and 57 years), both homozygous for valine-129, showed cerebellar ataxia and later dementia not associated with periodic electroencephalogram; brain PrPres was type 2. Genotyping of 205 Cretan controls showed that methionine-129 homozygosity, a susceptibility factor for sCJD, was significantly higher in this population than in other Caucasian populations (57.0% n = 205 vs. 41.5% n = 859, p < 0.0001). These data are the first to relate a high regional incidence rate for sCJD to the distribution of PRNP 129 genotypes in the local population; however, additional factors may be operational.


Asunto(s)
Amiloide/genética , Síndrome de Creutzfeldt-Jakob/patología , Precursores de Proteínas/genética , Factores de Edad , Anciano , Anciano de 80 o más Años , Western Blotting , Corteza Cerebral/patología , Síndrome de Creutzfeldt-Jakob/epidemiología , Síndrome de Creutzfeldt-Jakob/genética , Femenino , Genotipo , Grecia/epidemiología , Humanos , Inmunohistoquímica , Incidencia , Masculino , Persona de Mediana Edad , Proteínas Priónicas , Priones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA